isoalantolactone has been researched along with Cancer of Head in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, J; Li, C; Li, H; Li, L; Mei, X; Ren, F; Weng, Z; Wu, M; Zhang, H; Zhao, Y | 1 |
Fan, Y; Gao, H; Hu, J; Li, L; Liu, H; Wang, H; Weng, Z | 1 |
2 other study(ies) available for isoalantolactone and Cancer of Head
Article | Year |
---|---|
Isoalantolactone inhibits UM-SCC-10A cell growth via cell cycle arrest and apoptosis induction.
Topics: Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclin D; Flow Cytometry; G1 Phase Cell Cycle Checkpoints; Head and Neck Neoplasms; Humans; Mitochondria; rho GTP-Binding Proteins; Sesquiterpenes; Tetrazolium Salts; Thiazoles; Tumor Suppressor Protein p53 | 2013 |
Isoalantolactone Enhances the Radiosensitivity of UMSCC-10A Cells via Specific Inhibition of Erk1/2 Phosphorylation.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; G2 Phase; Head and Neck Neoplasms; Hep G2 Cells; Humans; MAP Kinase Signaling System; Phosphorylation; Radiation Tolerance; Radiation-Sensitizing Agents; Rats; Sesquiterpenes; Signal Transduction | 2015 |